"I'm very pleased to report we achieved the highest level of organic sales growth in the last decade, as the economy recovers from the pandemic lows of the prior year. This is a direct result of the investments we have made to transform our portfolio to one that is more specialized and focused on high growth end markets with sustainable solutions," said
The company cited strong demand for healthcare (up 22%) and consumer products (up 24%) as organic revenue increased 17% to
The company noted the following segment highlights:
The Color, Additives and Inks segment delivered record operating income of
The Specialty Engineered Materials segment also achieved its highest-ever quarterly operating income at $34 million, a 53% increase over the prior year. Demand conditions were robust in the quarter, in particular for composite technologies and new business gains in healthcare applications.
Despite significant supply chain disruptions, the company's Distribution segment also performed exceptionally well to start the year, highlighted by record quarterly operating income of
Second Quarter and Full Year 2021 Outlook
Commenting on the Company's 2021 outlook,
"As companies report their earnings this year and compare to 2020, there will be many examples of significant growth being delivered. This is the case for
The Company noted it will provide more details on its 2021 outlook during the webcast scheduled for
Pro Forma
The Company acquired the Clariant Masterbatch business ("CMB") on
Webcast Details
The webcast can be viewed live at avient.com/investors, or by clicking here: https://edge.media-server.com/mmc/p/eaivs28r. To participate in the audio-only portion of the call, dial 1-844-835-7433 (domestic) or 1-914-495-8589 (international) and provide conference ID number 6746706. There will be a question and answer session following the company's presentation and prepared remarks.
A recording of the webcast and the slide presentation will be available at avient.com/investors. In addition, a recording of the audio will be available for one week, beginning at
About
Forward-looking Statements
In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. They use words such as "will," "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; information systems failures and cyberattacks; our ability to consummate and successfully integrate acquisitions; and amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions. The above list of factors is not exhaustive.
We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the
Non-GAAP Reconciliation
The Company does not provide reconciliations of forward-looking non-GAAP financial measures, such as outlook for adjusted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because the Company is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition related costs, and other non-routine costs. Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted. For the same reasons, the Company is unable to address the probable significance of the unavailable information.
Attachment 1 |
|||||||
Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) |
|||||||
Three Months Ended |
|||||||
2021 |
2020 |
||||||
Sales |
$ |
1,162.3 |
$ |
711.5 |
|||
Operating Income |
120.4 |
52.8 |
|||||
Net income from continuing operations attributable to |
79.3 |
33.1 |
|||||
Basic earnings per share from continuing operations attributable to |
$ |
0.87 |
$ |
0.38 |
|||
Diluted earnings per share from continuing operations attributable to |
$ |
0.86 |
$ |
0.38 |
Senior management uses comparisons of adjusted net income from continuing operations attributable to
Three Months Ended |
Three Months Ended |
||||||||||||||
Reconciliation to Condensed Consolidated Statements of Income |
$ |
EPS |
$ |
EPS |
|||||||||||
Net income from continuing operations attributable to |
$ |
79.3 |
$ |
0.86 |
$ |
33.1 |
$ |
0.38 |
|||||||
Special items, after tax (Attachment 3) |
2.6 |
0.03 |
8.6 |
0.10 |
|||||||||||
Adjusted net income / EPS - excluding special items |
$ |
81.9 |
$ |
0.89 |
$ |
41.7 |
$ |
0.48 |
Attachment 2 |
|||||||
Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) |
|||||||
Three Months Ended |
|||||||
2021 |
2020 |
||||||
Sales |
$ |
1,162.3 |
$ |
711.5 |
|||
Cost of sales |
859.9 |
540.0 |
|||||
Gross margin |
302.4 |
171.5 |
|||||
Selling and administrative expense |
182.0 |
118.7 |
|||||
Operating income |
120.4 |
52.8 |
|||||
Interest expense, net |
(19.3) |
(9.4) |
|||||
Other income, net |
1.5 |
1.6 |
|||||
Income from continuing operations before income taxes |
102.6 |
45.0 |
|||||
Income taxes |
(22.9) |
(11.9) |
|||||
Net income from continuing operations |
79.7 |
33.1 |
|||||
Loss from discontinued operations, net of income taxes |
— |
(0.3) |
|||||
Net income |
79.7 |
32.8 |
|||||
Net income attributable to noncontrolling interests |
(0.4) |
— |
|||||
Net income attributable to |
$ |
79.3 |
$ |
32.8 |
|||
Earnings per share attributable to |
|||||||
Continuing operations |
$ |
0.87 |
$ |
0.38 |
|||
Discontinued operations |
— |
— |
|||||
Total |
$ |
0.87 |
$ |
0.38 |
|||
Earnings per share attributable to |
|||||||
Continuing operations |
$ |
0.86 |
$ |
0.38 |
|||
Discontinued operations |
— |
— |
|||||
Total |
$ |
0.86 |
$ |
0.38 |
|||
Cash dividends declared per share of common stock |
$ |
0.2125 |
$ |
0.2025 |
|||
Weighted-average shares used to compute earnings per common share: |
|||||||
Basic |
91.3 |
86.3 |
|||||
Diluted |
92.2 |
86.7 |
Attachment 3 |
|||||||
Summary of Special Items (Unaudited) (In millions, except per share data) |
|||||||
Special items (1) |
Three Months Ended March 31, |
||||||
2021 |
2020 |
||||||
Cost of sales: |
|||||||
Restructuring costs, including accelerated depreciation and amortization |
$ |
(1.8) |
$ |
— |
|||
Environmental remediation costs |
(0.5) |
(0.4) |
|||||
Reimbursement of previously incurred environmental costs |
4.5 |
0.2 |
|||||
Impact on cost of sales |
2.2 |
(0.2) |
|||||
Selling and administrative expense: |
|||||||
Restructuring, legal and other |
(1.3) |
(1.8) |
|||||
Acquisition earn-out adjustments |
— |
(1.0) |
|||||
Acquisition related costs |
(3.3) |
(6.7) |
|||||
Impact on selling and administrative expense |
(4.6) |
(9.5) |
|||||
Impact on operating income |
(2.4) |
(9.7) |
|||||
Other income, net |
— |
0.1 |
|||||
Impact on income from continuing operations before income taxes |
(2.4) |
(9.6) |
|||||
Income tax benefit on above special items |
0.9 |
2.0 |
|||||
Tax adjustments(2) |
(1.1) |
(1.0) |
|||||
Impact of special items on net income from continuing operations |
$ |
(2.6) |
$ |
(8.6) |
|||
Diluted earnings per common share impact |
$ |
(0.03) |
$ |
(0.10) |
|||
Weighted average shares used to compute adjusted earnings per share: |
|||||||
Diluted |
92.2 |
86.7 |
(1) |
Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the divestiture of operating businesses, joint ventures and equity investments; gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results. |
(2) |
Tax adjustments include the net tax benefit/(expense) from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments. |
Attachment 4 |
|||||||
Condensed Consolidated Balance Sheets (In millions) |
|||||||
(Unaudited) |
|
||||||
ASSETS |
|||||||
Current assets: |
|||||||
Cash and cash equivalents |
$ |
594.5 |
$ |
649.5 |
|||
Accounts receivable, net |
642.2 |
516.6 |
|||||
Inventories, net |
357.0 |
327.5 |
|||||
Other current assets |
122.7 |
108.5 |
|||||
Total current assets |
1,716.4 |
1,602.1 |
|||||
Property, net |
675.5 |
694.9 |
|||||
|
1,281.9 |
1,308.1 |
|||||
Intangible assets, net |
973.3 |
1,008.5 |
|||||
Operating lease assets, net |
80.9 |
80.9 |
|||||
Other non-current assets |
181.4 |
176.0 |
|||||
Total assets |
$ |
4,909.4 |
$ |
4,870.5 |
|||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||
Current liabilities: |
|||||||
Short-term and current portion of long-term debt |
$ |
18.8 |
$ |
18.6 |
|||
Accounts payable |
529.6 |
471.7 |
|||||
Current operating lease obligations |
24.3 |
25.1 |
|||||
Accrued expenses and other current liabilities |
290.9 |
285.6 |
|||||
Total current liabilities |
863.6 |
801.0 |
|||||
Non-current liabilities: |
|||||||
Long-term debt |
1,852.7 |
1,854.0 |
|||||
Pension and other post-retirement benefits |
111.3 |
115.0 |
|||||
Non-current operating lease obligations |
56.8 |
56.0 |
|||||
Other non-current liabilities |
303.0 |
332.8 |
|||||
Total non-current liabilities |
2,323.8 |
2,357.8 |
|||||
SHAREHOLDERS' EQUITY |
|||||||
|
1,707.0 |
1,697.1 |
|||||
Noncontrolling interest |
15.0 |
14.6 |
|||||
Total equity |
1,722.0 |
1,711.7 |
|||||
Total liabilities and equity |
$ |
4,909.4 |
$ |
4,870.5 |
Attachment 5 |
|||||||
Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) |
|||||||
Three Months Ended March 31, |
|||||||
2021 |
2020 |
||||||
Operating Activities |
|||||||
Net income |
$ |
79.7 |
$ |
32.8 |
|||
Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||
Depreciation and amortization |
36.6 |
19.9 |
|||||
Accelerated depreciation and amortization |
0.5 |
— |
|||||
Share-based compensation expense |
2.7 |
2.1 |
|||||
Changes in assets and liabilities, net of the effect of acquisitions: |
|||||||
Increase in accounts receivable |
(137.6) |
(56.9) |
|||||
Increase in inventories |
(35.1) |
(13.0) |
|||||
Increase in accounts payable |
67.3 |
44.6 |
|||||
Decrease in pension and other post-retirement benefits |
(7.1) |
(3.2) |
|||||
Increase in post-acquisition earnout liabilities |
— |
1.0 |
|||||
Decrease in accrued expenses and other assets and liabilities, net |
(3.4) |
(19.1) |
|||||
Payment of post-acquisition date earnout liability |
— |
(21.0) |
|||||
Net cash provided (used) by operating activities |
3.6 |
(12.8) |
|||||
Investing activities |
|||||||
Capital expenditures |
(16.5) |
(11.1) |
|||||
Net proceeds from divestiture |
— |
7.1 |
|||||
Net proceeds (used) provided by other assets |
(2.0) |
5.2 |
|||||
Net cash (used) provided by investing activities |
(18.5) |
1.2 |
|||||
Financing activities |
|||||||
Purchase of common shares for treasury |
(4.2) |
(13.6) |
|||||
Cash dividends paid |
(19.5) |
(15.6) |
|||||
Repayment of long-term debt |
(2.3) |
(2.0) |
|||||
Payments of withholding tax on share awards |
(3.1) |
(1.3) |
|||||
Equity offering proceeds, net of underwriting discount and issuance costs |
— |
496.3 |
|||||
Payment of acquisition date earnout liability |
— |
(32.9) |
|||||
Net cash (used) provided by financing activities |
(29.1) |
430.9 |
|||||
Effect of exchange rate changes on cash |
(11.0) |
(3.8) |
|||||
(Decrease) increase in cash and cash equivalents |
(55.0) |
415.5 |
|||||
Cash and cash equivalents at beginning of year |
649.5 |
864.7 |
|||||
Cash and cash equivalents at end of period |
$ |
594.5 |
$ |
1,280.2 |
Attachment 6 |
|
Business Segment Operations (Unaudited) |
(In millions) |
Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker. These costs are included in Corporate and eliminations. |
Three Months Ended |
|||||||
2021 |
2020 |
||||||
Sales: |
|||||||
Color, Additives and Inks |
$ |
609.3 |
$ |
256.5 |
|||
Specialty Engineered Materials |
216.5 |
185.3 |
|||||
Distribution |
362.7 |
289.5 |
|||||
Corporate and eliminations |
(26.2) |
(19.8) |
|||||
Sales |
$ |
1,162.3 |
$ |
711.5 |
|||
Gross margin: |
|||||||
Color, Additives and Inks |
$ |
197.5 |
$ |
89.4 |
|||
Specialty Engineered Materials |
64.7 |
52.6 |
|||||
Distribution |
39.3 |
33.6 |
|||||
Corporate and eliminations |
0.9 |
(4.1) |
|||||
Gross margin |
$ |
302.4 |
$ |
171.5 |
|||
Selling and administrative expense: |
|||||||
Color, Additives and Inks |
$ |
108.7 |
$ |
48.9 |
|||
Specialty Engineered Materials |
30.5 |
30.3 |
|||||
Distribution |
15.3 |
14.2 |
|||||
Corporate and eliminations |
27.5 |
25.3 |
|||||
Selling and administrative expense |
$ |
182.0 |
$ |
118.7 |
|||
Operating income: |
|||||||
Color, Additives and Inks |
$ |
88.8 |
$ |
40.5 |
|||
Specialty Engineered Materials |
34.2 |
22.3 |
|||||
Distribution |
24.0 |
19.4 |
|||||
Corporate and eliminations |
(26.6) |
(29.4) |
|||||
Operating income |
$ |
120.4 |
$ |
52.8 |
|||
Earnings before interest, taxes, depreciation and amortization (EBITDA): |
|||||||
Color, Additives and Inks |
$ |
116.2 |
$ |
51.4 |
|||
Specialty Engineered Materials |
42.0 |
29.8 |
|||||
Distribution |
24.2 |
19.5 |
|||||
Corporate and eliminations |
(24.9) |
(28.0) |
|||||
Other income, net |
1.5 |
1.6 |
|||||
EBITDA |
$ |
159.0 |
$ |
74.3 |
Attachment 7 |
|
Reconciliation of Non-GAAP Financial Measures (Unaudited) |
(In millions, except per share data) |
Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance. In addition, operating income before the effect of special items is a component of |
Three Months Ended |
|||||||
Reconciliation to Consolidated Statements of Income |
2021 |
2020 |
|||||
Sales |
$ |
1,162.3 |
$ |
711.5 |
|||
Gross margin - GAAP |
302.4 |
171.5 |
|||||
Special items in gross margin (Attachment 3) |
(2.2) |
0.2 |
|||||
Adjusted Gross margin |
$ |
300.2 |
$ |
171.7 |
|||
Adjusted Gross margin as a percent of sales |
25.8 |
% |
24.1 |
% |
|||
Operating income - GAAP |
120.4 |
52.8 |
|||||
Special items in operating income (Attachment 3) |
2.4 |
9.7 |
|||||
Adjusted Operating income |
$ |
122.8 |
$ |
62.5 |
|||
Adjusted Operating income as a percent of sales |
10.6 |
% |
8.8 |
% |
The table below reconciles pre-special income tax expense and the pre-special effective tax rate to their most comparable US GAAP figures.
Three Months Ended |
|||||||||||||||||||||||
2021 |
2020 |
||||||||||||||||||||||
GAAP |
Special |
Adjusted |
GAAP |
Special I |
Adjusted |
||||||||||||||||||
Income from continuing operations before income taxes |
$ |
102.6 |
$ |
2.4 |
$ |
105.0 |
$ |
45.0 |
$ |
9.6 |
$ |
54.6 |
|||||||||||
Income tax expense - GAAP |
(22.9) |
— |
(22.9) |
(11.9) |
— |
(11.9) |
|||||||||||||||||
Income tax impact of special items (Attachment 3) |
— |
(0.9) |
(0.9) |
— |
(2.0) |
(2.0) |
|||||||||||||||||
Tax adjustments (Attachment 3) |
— |
1.1 |
1.1 |
— |
1.0 |
1.0 |
|||||||||||||||||
Income tax (expense) benefit |
$ |
(22.9) |
$ |
0.2 |
$ |
(22.7) |
$ |
(11.9) |
$ |
(1.0) |
$ |
(12.9) |
|||||||||||
Effective Tax Rate(1) |
22.3 |
% |
21.6 |
% |
26.5 |
% |
23.7 |
% |
(1) Rates may not recalculate from figures presented herein due to rounding |
The following pro forma adjustments are referenced by management to provide comparable business performance by incorporating the Clariant Masterbatch business in periods prior to the acquisition date (
Reconciliation of Pro Forma Adjusted Earnings per Share: |
Three Months Ended |
||
Net income from continuing operations attributable to |
$ |
33.1 |
|
Special items, after tax (Attachment 3) |
8.6 |
||
Adjusted net income from continuing operations excluding special items |
41.7 |
||
Clariant MB pro forma adjustments to net income from continuing operations(2) |
7.8 |
||
Pro forma adjusted net income from continuing operations attributable to |
$ |
49.5 |
|
Weighted average diluted shares |
86.7 |
||
Pro forma impact to diluted shares from |
6.1 |
||
Pro forma weighted average diluted shares |
92.8 |
||
Adjusted EPS - excluding special items pro forma for Clariant MB acquisition |
$ |
0.53 |
Year Ended |
|||||||||||||||||||
Reconciliation of Pro Forma Adjusted |
|
Special |
Adjusted |
Clariant MB Pro Forma |
Pro Forma |
||||||||||||||
Sales |
$ |
3,242.1 |
$ |
— |
$ |
3,242.1 |
$ |
540.4 |
$ |
3,782.5 |
|||||||||
Operating income |
$ |
189.3 |
$ |
73.7 |
$ |
263.0 |
$ |
45.0 |
$ |
308.0 |
|||||||||
Interest expense, net |
(74.6) |
10.1 |
(64.5) |
(18.1) |
(82.6) |
||||||||||||||
Other income, net |
24.3 |
(17.6) |
6.7 |
— |
6.7 |
||||||||||||||
Income taxes |
(5.2) |
(41.4) |
(46.6) |
(6.2) |
(52.8) |
||||||||||||||
Net income attributable to noncontrolling |
(1.8) |
— |
(1.8) |
— |
(1.8) |
||||||||||||||
Net income from continuing operations |
$ |
132.0 |
$ |
24.8 |
$ |
156.8 |
$ |
20.7 |
$ |
177.5 |
|||||||||
Weighted average diluted shares |
90.6 |
||||||||||||||||||
Impact to diluted shares from |
1.5 |
||||||||||||||||||
Pro forma weighted average diluted shares |
92.1 |
||||||||||||||||||
Pro forma adjusted EPS |
$ |
1.93 |
(2) |
Pro forma adjustments for the periods prior to the acquisition date ( |
Year Ended |
|||||||||||||||||||
Reconciliation of Pro Forma Adjusted |
|
Special |
Adjusted |
Clariant MB Pro Forma |
Pro Forma |
||||||||||||||
Sales |
$ |
2,862.7 |
$ |
— |
$ |
2,862.7 |
$ |
1,118.6 |
$ |
3,981.3 |
|||||||||
Operating income |
$ |
156.8 |
$ |
71.7 |
$ |
228.5 |
$ |
72.9 |
$ |
301.4 |
|||||||||
Interest expense, net |
(59.5) |
— |
(59.5) |
(33.4) |
(92.9) |
||||||||||||||
Other income, net |
12.1 |
(10.0) |
2.1 |
— |
2.1 |
||||||||||||||
Income taxes |
(33.7) |
(5.9) |
(39.6) |
(9.1) |
(48.7) |
||||||||||||||
Net income attributable to noncontrolling |
(0.2) |
— |
(0.2) |
— |
(0.2) |
||||||||||||||
Net income from continuing operations |
$ |
75.5 |
$ |
55.8 |
$ |
131.3 |
$ |
30.4 |
$ |
161.7 |
|||||||||
Weighted average diluted shares |
77.7 |
||||||||||||||||||
Impact to diluted shares from |
15.3 |
||||||||||||||||||
Pro forma weighted average diluted shares |
93.0 |
||||||||||||||||||
Pro forma adjusted EPS |
$ |
1.74 |
(3) |
Pro forma adjustments for the periods prior to the acquisition date ( |
Reconciliation of EBITDA by Segment |
Three Months Ended |
Year Ended |
|||||||||||||||||
2021 |
2020 |
2020 |
2019 |
2018 |
|||||||||||||||
Operating income: |
|||||||||||||||||||
Color, Additives and Inks |
$ |
88.8 |
$ |
40.5 |
$ |
180.8 |
$ |
147.4 |
$ |
158.5 |
|||||||||
Specialty Engineered Materials |
34.2 |
22.3 |
94.4 |
83.7 |
72.3 |
||||||||||||||
Distribution |
24.0 |
19.4 |
69.5 |
75.4 |
71.5 |
||||||||||||||
Corporate and eliminations |
(26.6) |
(29.4) |
(155.4) |
(149.7) |
(123.7) |
||||||||||||||
Operating income |
$ |
120.4 |
$ |
52.8 |
$ |
189.3 |
$ |
156.8 |
$ |
178.6 |
|||||||||
Items below OI in Corporate: |
|||||||||||||||||||
Other income, net |
$ |
1.5 |
$ |
1.6 |
$ |
24.3 |
$ |
12.1 |
$ |
(12.9) |
|||||||||
Depreciation & amortization: |
|||||||||||||||||||
Color, Additives and Inks |
$ |
27.4 |
$ |
10.9 |
$ |
75.1 |
$ |
42.7 |
$ |
44.3 |
|||||||||
Specialty Engineered Materials |
7.8 |
7.5 |
30.0 |
29.5 |
23.2 |
||||||||||||||
Distribution |
0.2 |
0.1 |
0.7 |
0.5 |
0.7 |
||||||||||||||
Corporate and eliminations |
1.7 |
1.4 |
9.2 |
5.4 |
4.4 |
||||||||||||||
Depreciation & Amortization |
$ |
37.1 |
$ |
19.9 |
$ |
115.0 |
$ |
78.1 |
$ |
72.6 |
|||||||||
EBITDA |
|||||||||||||||||||
Color, Additives and Inks |
$ |
116.2 |
$ |
51.4 |
$ |
255.9 |
$ |
190.1 |
$ |
202.8 |
|||||||||
Specialty Engineered Materials |
42.0 |
29.8 |
124.4 |
113.2 |
95.5 |
||||||||||||||
Distribution |
24.2 |
19.5 |
70.2 |
75.9 |
72.2 |
||||||||||||||
Corporate and eliminations |
(24.9) |
(28.0) |
(146.2) |
(144.3) |
(119.3) |
||||||||||||||
EBITDA |
$ |
159.0 |
$ |
74.3 |
$ |
328.6 |
$ |
247.0 |
$ |
238.3 |
|||||||||
EBITDA as a % of Sales: |
|||||||||||||||||||
Color, Additives and Inks |
19.1 |
% |
20.0 |
% |
17.0 |
% |
18.9 |
% |
19.4 |
% |
|||||||||
Specialty Engineered Materials |
19.4 |
% |
16.1 |
% |
17.6 |
% |
15.2 |
% |
14.8 |
% |
|||||||||
Distribution |
6.7 |
% |
6.7 |
% |
6.3 |
% |
6.4 |
% |
5.7 |
% |
Reconciliation of Pro Forma EBITDA - Color, |
Three Months Ended |
Year Ended |
|||||||||||||
2020 |
2020 |
2019 |
2018 |
||||||||||||
Sales: |
|||||||||||||||
Color, Additives and Inks |
$ |
256.5 |
$ |
1,502.9 |
$ |
1,003.8 |
$ |
1,046.5 |
|||||||
Clariant MB pro forma adjustments(4) |
279.4 |
540.4 |
1,118.6 |
1,209.8 |
|||||||||||
Pro forma sales |
$ |
535.9 |
$ |
2,043.3 |
$ |
2,122.4 |
$ |
2,256.3 |
|||||||
Operating income: |
|||||||||||||||
Color, Additives and Inks |
$ |
40.5 |
$ |
180.8 |
$ |
147.4 |
$ |
158.5 |
|||||||
Clariant MB pro forma adjustments(4) |
23.0 |
45.0 |
72.9 |
80.3 |
|||||||||||
Pro forma operating income |
$ |
63.5 |
$ |
225.8 |
$ |
220.3 |
$ |
238.8 |
|||||||
Depreciation & amortization: |
|||||||||||||||
Color, Additives and Inks |
$ |
10.9 |
$ |
75.1 |
$ |
42.7 |
$ |
44.3 |
|||||||
Clariant MB pro forma adjustments(4) |
15.1 |
30.1 |
60.3 |
61.2 |
|||||||||||
Pro forma depreciation & amortization |
$ |
26.0 |
$ |
105.2 |
$ |
103.0 |
$ |
105.5 |
|||||||
Earnings Before Interest, Taxes, Depreciation |
|||||||||||||||
Color, Additives and Inks |
$ |
51.4 |
$ |
255.9 |
$ |
190.1 |
$ |
202.8 |
|||||||
Clariant MB pro forma adjustments(4) |
38.1 |
75.1 |
133.2 |
141.5 |
|||||||||||
Pro forma EBITDA |
$ |
89.5 |
$ |
331.0 |
$ |
323.3 |
$ |
344.3 |
|||||||
Pro forma EBITDA as a % of Sales |
16.7 |
% |
16.2 |
% |
15.2 |
% |
15.3 |
% |
Three Months Ended |
Year Ended |
||||||||||||||||||
Reconciliation to Adjusted EBITDA: |
2021 |
2020 |
2020 |
2019 |
2018 |
||||||||||||||
Net income from continuing operations – GAAP |
$ |
79.7 |
$ |
33.1 |
$ |
133.8 |
$ |
75.7 |
$ |
87.4 |
|||||||||
Income tax expense |
22.9 |
11.9 |
5.2 |
33.7 |
14.4 |
||||||||||||||
Interest expense |
19.3 |
9.4 |
74.6 |
59.5 |
62.8 |
||||||||||||||
Debt extinguishment cost |
— |
— |
1.1 |
||||||||||||||||
Depreciation and amortization from continuing operations |
37.1 |
19.9 |
115.0 |
78.1 |
72.6 |
||||||||||||||
EBITDA |
$ |
159.0 |
$ |
74.3 |
$ |
328.6 |
$ |
247.0 |
$ |
238.3 |
|||||||||
Special items, before tax |
2.4 |
9.6 |
66.2 |
61.7 |
59.5 |
||||||||||||||
Interest expense included in special items |
— |
— |
(10.1) |
— |
— |
||||||||||||||
Accelerated depreciation included in special items |
(0.5) |
— |
(3.2) |
— |
(3.0) |
||||||||||||||
Adjusted EBITDA |
$ |
160.9 |
$ |
83.9 |
$ |
381.6 |
$ |
308.7 |
$ |
294.8 |
Reconciliation of Pro |
Three Months Ended |
||
Sales |
$ |
711.5 |
|
Clariant MB pro forma adjustment to sales(4) |
279.4 |
||
Pro forma sales |
$ |
990.9 |
(4) |
Pro forma adjustments for the periods prior to the acquisition date ( |
View original content to download multimedia:http://www.prnewswire.com/news-releases/avient-announces-record-first-quarter-2021-results-increases-full-year-guidance-301281089.html
SOURCE
Investor Relations Contact: Giuseppe (Joe) Di Salvo, Vice President, Treasurer and Investor Relations, Avient Corporation, +1 440-930-1921, giuseppe.disalvo@avient.com, or Media Contact: Kyle G. Rose, Vice President, Corporate Communications, Avient Corporation, +1 440-930-3162, kyle.rose@avient.com